What Are the Indications for Lumbar Puncture in Patients with Lyme Disease?

Current Problems in Dermatology

Volumn 37, Issue , 2009, Pages 200-206

  Rupprecht, Tobias A ^a   Pfister, Hans Walter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CEFTRIAXONE; CEPHALOSPORIN; CXCL13 CHEMOKINE; DOXYCYCLINE; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN M;

ANTIBIOTIC THERAPY; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; BELL PALSY; BORRELIA BURGDORFERI; BORRELIA INFECTION; CARCINOMATOUS MENINGITIS; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG HYPERSENSITIVITY; DRUG PENETRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENCEPHALOMYELITIS; ERYTHEMA CHRONICUM MIGRANS; FACIAL NERVE PARALYSIS; FUNGAL MENINGITIS; GUILLAIN BARRE SYNDROME; HUMAN; LABORATORY DIAGNOSIS; LEPTOSPIROSIS; LUMBAR PUNCTURE; LYME DISEASE; MENINGITIS; MULTIPLE SCLEROSIS; NEURITIS; NONHUMAN; PLEOCYTOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPEAT PROCEDURE; REVIEW; SARCOIDOSIS; SYPHILIS; TICK BITE; TICK BORNE DISEASE; TRANSPORT HOST; TREATMENT DURATION; VIRUS MENINGITIS; ARTICLE; PUNCTURE; STANDARD;

ANTIBODIES, BACTERIAL; HUMANS; IMMUNOGLOBULIN M; LYME NEUROBORRELIOSIS; SPINAL PUNCTURE;

EID: 67649528650     PISSN: 14215721     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000213078     Document Type: Review

References (17)

1. Huppertz HI, Bohme M, Standaert SM, Karch H, Plotkin SA: Incidence of Lyme borreliosis in the Wurzburg region of Germany. Eur J Clin Microbiol Infect Dis 1999;18:697-703.
2. Hengge UR, Tannapfel A, Tyring SK, Erbel R, Arendt G, Ruzicka T: Lyme borreliosis. Lancet Infect Dis 2003;3:489-500.
3. Wilske B, Fingerle V, Schu lte-Spechtel U: Microbiological and serological diagnosis of Lyme borrelio-sis. FEMS Immunol Med Microbiol 2007;49:13-21.
4. Pfister HW, Wilske B, Weber K: Lyme borreliosis: basic science and clinical aspects. Lancet 1994;343: 1013-1016.
5. Hansen K, Lebech AM: The clinical and epidemio-logical profile of Lyme neuroborreliosis in Denmark 1985-1990: a prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain 1992; 115(par t 2):399-423.
6. Wilske B, Busch U, Eiffert H, Fingerle V, Pfister HW, Rossler D, Preac-Mursic V: Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany. Med Microbiol Immunol (Berl) 1996;184:195-201.
7. Ornstein K, Berglund J, Nilsson I, Norrby R, Bergstrom S: Characterization of Lyme borreliosis isolates from patients with erythema migrans and neuroborreliosis in southern Sweden. J Clin Microbiol 2001;39:1294-1298.
8. Steere AC: Lyme disease. N Engl J Med 2001;345: 115-125.
9. Christen HJ: Lyme neuroborreliosis in children. Ann Med 1996;28:235-240.
10. Pfister HW, Rupprecht TA: Clinical aspects of neu-roborreliosis and post-Lyme disease syndrome in adu lt patients. Int J Med Microbiol 2006;9:11-16.
11. Kaiser R, Kern A, Kampa D, Neumann-Haefelin D: Prevalence of antibodies to Borrelia burgdorferi and tick-borne encephalitis virus in an endemic region in southern Germany. Zentralbl Bakteriol 1997;286:534-541.
12. Hammers-Berggren S, Hansen K, Lebech AM, Karlsson M: Borrelia burgdorferi-specific intrathe-cal antibody production in neuroborreliosis: a follow-up study. Neurology 1993;43:169-175.
13. Karlsson M, Hovind-Hougen K, Svenungsson B, Stiernstedt G: Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. J Clin Microbiol 1990;28:473-479.
14. Rupprecht TA, Pfister HW, Angele B, Kastenbauer S, Wilske B, Koedel U: The chemokine CXCL13 (BLC): a putative diagnostic marker for neurobor-reliosis. Neurology 2005;65:448-450.
15. Ruppre c ht TA, Koede l U, A ngele B , Fi ngerle V, Pf ister HW: Cytokine CXCL13 - a possible early CSF marker for neuroborreliosis (in German). Nervenarzt 2006;77:470-473.
16. Halperin JJ, Shapiro ED, Logigian E, Belman AL, Dotevall L, Wormser GP, Krupp L, Gronseth G, Bever CT Jr: Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurolog y 2007;69:91-102.
17. Kalish RA, Kaplan RF, Taylor E, Jones-Woodward L, Workman K, Steere AC: Evaluation of study patients with Lyme disease, 10-20-year follow-up. J Infect Dis 2001;183:453-460.